| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $267.1M | +75.3% |
| SG&A Expense | $59.1M | +4.9% |
| Operating Income | -$326.2M | -63.0% |
| Pre-tax Income | -$302.8M | -65.7% |
| Income Tax | $471K | — |
| Net Income | -$303.3M | -65.9% |
| EPS (Basic) | -$13.48 | -32.0% |
| EPS (Diluted) | -$13.48 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $357.3M | +65.9% |
| Short-term Investments | $242.0M | +36.6% |
| Current Assets | $610.9M | +51.1% |
| Total Assets | $937.9M | +94.1% |
| Current Liabilities | $59.8M | +59.2% |
| Total Liabilities | $59.8M | +58.7% |
| Stockholders' Equity | $878.1M | +97.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$249.1M | -89.0% |
| Capital Expenditures | $56K | — |
| Investing Cash Flow | -$311.1M | -25.2% |
| Financing Cash Flow | $702.2M | +36.5% |
| Free Cash Flow | -$249.1M | -89.1% |
| -32.0% |